The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.

MLA

Jr.Hackler, László, et al. “The Curcumin Analog C-150, Influencing NF-ΚB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.” PLoS ONE, vol. 11, no. 3, Mar. 2016, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0149832.

APA

Jr.Hackler, L., Ózsvári, B., Gyuris, M., Sipos, P., Fábián, G., Molnár, E., Marton, A., Faragó, N., Mihály, J., Nagy, L. I., Szénási, T., Diron, A., Párducz, Á., Kanizsai, I., & Puskás, L. G. (2016). The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo. PLoS ONE, 11(3), 1–16. https://doi.org/10.1371/journal.pone.0149832

Chicago

Jr.Hackler, László, Béla Ózsvári, Márió Gyuris, Péter Sipos, Gabriella Fábián, Eszter Molnár, Annamária Marton, et al. 2016. “The Curcumin Analog C-150, Influencing NF-ΚB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.” PLoS ONE 11 (3): 1–16. doi:10.1371/journal.pone.0149832.